moclobemide has been researched along with ADDH in 6 studies
Moclobemide: A reversible inhibitor of monoamine oxidase type A; (RIMA); (see MONOAMINE OXIDASE INHIBITORS) that has antidepressive properties.
moclobemide : A member of the class of benzamides that is benzamide substituted by a chloro group at position 4 and a 2-(morpholin-4-yl)ethyl group at the nitrogen atom. It acts as a reversible monoamine oxidase inhibitor and is used in the treatment of depression.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The pharmacotherapy of the hyperkinetic syndrome with amphetamines was inaugurated by Bradley in 1937." | 2.67 | [Effectiveness and tolerance of the selective MAO-A inhibitor moclobemide in children with hyperkinetic syndrome]. ( Friese, HJ; Menzel, M; Nissen, G; Trott, GE, 1991) |
| "Moclobemide is a specific and reversible monoamine oxidase-A (MAO-A) inhibitor." | 1.31 | Treatment of comorbid opiate addiction and attention-deficit hyperactivity disorder (residual type) with moclobemide: a case report. ( Bailly, D; De Lenclave, MB; Vaiva, G, 2002) |
| "Moclobemide has shown unequivocal antidepressant activity against serious depressive illness in 4 placebo-controlled double-blind trials." | 1.29 | Reversible and selective inhibitors of monoamine oxidase A in mental and other disorders. ( Gimbrett, R; Priest, RG; Roberts, M; Steinert, J, 1995) |
| "Moclobemide was well tolerated by these patients, although two complained of mild gastrointestinal disturbances during the first week of therapy." | 1.28 | Use of moclobemide in children with attention deficit hyperactivity disorder. ( Friese, HJ; Menzel, M; Nissen, G; Trott, GE, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (83.33) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Priest, RG | 1 |
| Gimbrett, R | 1 |
| Roberts, M | 1 |
| Steinert, J | 1 |
| Myronuk, LD | 1 |
| Weiss, M | 1 |
| Cotter, L | 1 |
| Wappler, F | 1 |
| Köchling, A | 1 |
| Roewer, N | 1 |
| Vaiva, G | 1 |
| De Lenclave, MB | 1 |
| Bailly, D | 1 |
| Trott, GE | 2 |
| Friese, HJ | 2 |
| Menzel, M | 2 |
| Nissen, G | 2 |
1 trial available for moclobemide and ADDH
| Article | Year |
|---|---|
[Effectiveness and tolerance of the selective MAO-A inhibitor moclobemide in children with hyperkinetic syndrome].
Topics: Attention; Attention Deficit Disorder with Hyperactivity; Benzamides; Child; Electrocardiography; Fe | 1991 |
5 other studies available for moclobemide and ADDH
| Article | Year |
|---|---|
Reversible and selective inhibitors of monoamine oxidase A in mental and other disorders.
Topics: Alzheimer Disease; Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hyperactivity; | 1995 |
Combined treatment with moclobemide and methylphenidate for comorbid major depression and adult attention-deficit/hyperactivity disorder.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Benzamides; Comorbidity; Depressive Disorder; | 1996 |
[Are monamine oxidase inhibitors in disposition to malignant hyperthermia contraindicated? Discussion based on a case report].
Topics: Anesthetics, Inhalation; Attention Deficit Disorder with Hyperactivity; Benzamides; Child; Contraind | 1996 |
Treatment of comorbid opiate addiction and attention-deficit hyperactivity disorder (residual type) with moclobemide: a case report.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Diagnosis, Dual (Psychiatry); Humans; Male; Mo | 2002 |
Use of moclobemide in children with attention deficit hyperactivity disorder.
Topics: Adolescent; Adult; Attention; Attention Deficit Disorder with Hyperactivity; Behavior; Benzamides; B | 1992 |